SCOPUS 정보 검색 플랫폼

Neuro-Oncology

Volumn 12, Issue 4, 2010, Pages 319-

Immunotherapy for glioblastoma: A long and winding road

(1) Weller, Michael a

a UNIVERSITY HOSPITAL ZURICH (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CANCER CELL CULTURE; CANCER SURVIVAL; CELL FUNCTION; COCULTURE; DENDRITIC CELL; DRUG TOLERABILITY; EDITORIAL; GLIOBLASTOMA; HUMAN; IMMUNOTHERAPY; MONOCYTE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PROGRESSION FREE SURVIVAL; RECURRENT CANCER; ANIMAL; IMMUNOLOGY; METABOLISM; NOTE;

ANIMALS; ANTIGENS, CD14; COCULTURE TECHNIQUES; GLIOBLASTOMA; HUMANS; IMMUNOTHERAPY; MONOCYTES;

EID: 77954629353 PISSN: 15228517 EISSN: 15235866 Source Type: Journal
DOI: 10.1093/neuonc/noq027 Document Type: Editorial

Times cited : (4)

References (4)

1
- 77954641353
- Normal human monocytes exposed to glioma cells acquire myeloid derived suppressor cell-like properties
- Rodrigues JC, Gonzalez GC, Zhang L, Ibrahim G, Kelly JJ, Gustafson M, Dietz AB, Forsyth PA, Yong VW, Parney IF. Normal human monocytes exposed to glioma cells acquire myeloid derived suppressor cell-like properties. Neuro-Oncology 2010;12(4):351-365.
- (2010) Neuro-Oncology , vol.12 , Issue.4 , pp. 351-365
- Rodrigues, J.C.¹ Gonzalez, G.C.² Zhang, L.³ Ibrahim, G.⁴ Kelly, J.J.⁵ Gustafson, M.⁶ Dietz, A.B.⁷ Forsyth, P.A.⁸ Yong, V.W.⁹ Parney, I.F.¹⁰

2
- 77954634714
- Intratumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironment
- Pellegatta S, Poliani PL, Stucchi E, Corno D, Agnese Colombo C, Orzan F, Ravanini M, Finocchiaro G. Intratumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironment. Neuro-Oncology 2010;12(4):377-388.
- (2010) Neuro-Oncology , vol.12 , Issue.4 , pp. 377-388
- Pellegatta, S.¹ Poliani, P.L.² Stucchi, E.³ Corno, D.⁴ Agnese Colombo, C.⁵ Orzan, F.⁶ Ravanini, M.⁷ Finocchiaro, G.⁸

3
- 77954646180
- Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma. A phase II study
- Carpentier A, Metellus P, Ursu R, Zohar S, Lafitte F, Barrié M, Meng Y, Richard M, Parizot C, Laigle-Donadey F, Gorochov G, Psimaras D, Sanson M, Tibi A, Chinot O, Carpentier A. Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma. A phase II study. Neuro-Oncology 2010;12(4):401-408.
- (2010) Neuro-Oncology , vol.12 , Issue.4 , pp. 401-408
- Carpentier, A.¹ Metellus, P.² Ursu, R.³ Zohar, S.⁴ Lafitte, F.⁵ Barrié, M.⁶ Meng, Y.⁷ Richard, M.⁸ Parizot, C.⁹ Laigle-Donadey, F.¹⁰ Gorochov, G.¹¹ Psimaras, D.¹² Sanson, M.¹³ Tibi, A.¹⁴ Chinot, O.¹⁵ Carpentier, A.¹⁶

4
- 67650688162
- The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients
- Heimberger AB, Sampson JH. The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients. Expert Opin Biol Ther 2009;9:1087-1098.
- (2009) Expert Opin Biol Ther , vol.9 , pp. 1087-1098
- Heimberger, A.B.¹ Sampson, J.H.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.